Table 3. Therapy outcomes of PAD in women.
| Medical therapy, cilostazol | No gender-based difference to benefit 38 |
| Supervised exercise | No gender-based difference to benefit 41 |
| Surgical revascularization outcomes | |
| Graft failure | Higher incidence in women 47 48 49 |
| Wound infection | Higher incidence in women 47 48 49 |
| Bleeding complications | Higher incidence in women 47 48 49 |
| Limb loss after surgery | Higher incidence in women 47 48 49 |
| Mortality | Higher incidence in women 47 48 49 |
| Endovascular revascularization outcomes | |
| Technical success | Higher incidence in women 51 |
| Embolic events | Higher incidence in women 51 |
| Patency rates after CLI | Higher in women 52 |
| Limb loss after EVI | Similar for males and females 52 |
| Outcomes after iliac stenting | Similar primary and secondary patency 56 |
| Outcomes after SFA POBA/stenting | Improved patency in females 52 |
| Outcomes after tibial angioplasty | Improved patency in females 52 |
Abbreviations: CLI, critical limb ischemia; EVI, endovascular intervention; PAD, peripheral arterial disease; POBA, plain old balloon angioplasty; SFA, superficial femoral artery.